Molecular and clinical pharmacology of psoriasis

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/136054/1/cpt1974165part2919.pd

Perturbation expansions for a class of singular potentials

Harrell's modified perturbation theory [Ann. Phys. 105, 379-406 (1977)] is applied and extended to obtain non-power perturbation expansions for a class of singular Hamiltonians H = -D^2 + x^2 + A/x^2 + lambda/x^alpha, (A\geq 0, alpha > 2), known as generalized spiked harmonic oscillators. The perturbation expansions developed here are valid for small values of the coupling lambda > 0, and they extend the results which Harrell obtained for the spiked harmonic oscillator A = 0. Formulas for the the excited-states are also developed.Comment: 23 page

Variational analysis for a generalized spiked harmonic oscillator

A variational analysis is presented for the generalized spiked harmonic oscillator Hamiltonian operator H, where H = -(d/dx)^2 + Bx^2+ A/x^2 + lambda/x^alpha, and alpha and lambda are real positive parameters. The formalism makes use of a basis provided by exact solutions of Schroedinger's equation for the Gol'dman and Krivchenkov Hamiltonian (alpha = 2), and the corresponding matrix elements that were previously found. For all the discrete eigenvalues the method provides bounds which improve as the dimension of the basis set is increased. Extension to the N-dimensional case in arbitrary angular-momentum subspaces is also presented. By minimizing over the free parameter A, we are able to reduce substantially the number of basis functions needed for a given accuracy.Comment: 15 pages, 1 figur

Neuropsychological Test Performance in African-American and White Patients with Alzheimer's Disease

Little information exists on the performance of black versus white patients with Alzheimer's disease on neuropsychological tests for dementia.In this study, we compared performance on the CERAD (Consortium to Establish a Registry for Alzheimer's Disease) neuropsychological battery between white (n equals 830) and black (n equals 158) patients with Alzheimer's disease enrolled in the CERAD study at 23 university medical centers in the United States. The black patients were older, had fewer years of formal education, and were more impaired in their activities of daily living than were the white patients. After controlling for these characteristics and for duration of the disease and severity of dementia, there were differences in the performance of black and white patients on several of the cognitive measures. Black patients scored lower than whites on tests of visual naming and constructional praxis and on the Mini-Mental State Examination. There were no statistical differences in performance on tests of fluency and word list memory. These findings suggest that cultural or experiential differences may modify performance on specific neuropsychological tests. These factors, in addition to age and educational background, should be considered when interpreting performance on neuropsychological tests in elderly black patients with dementia

Asymptotic iteration method for eigenvalue problems

An asymptotic interation method for solving second-order homogeneous linear differential equations of the form y'' = lambda(x) y' + s(x) y is introduced, where lambda(x) \neq 0 and s(x) are C-infinity functions. Applications to Schroedinger type problems, including some with highly singular potentials, are presented.Comment: 14 page

Managing grassland for wildlife: the effects of rotational burning on tick presence and abundance in African savannah habitat

Ticks are obligate blood-feeding ectoparasites that have negative effects on animals through blood loss and vectoring disease. Controlling ticks is a major aspect of wildlife management in many areas, including African savannah where ticks are a long-standing problem. Rotational burning of vegetation is widely thought to reduce ticks but empirical data are lacking. We investigate the effect of block rotational burning on tick populations in a South African wildlife reserve. We measured tick presence/abundance using tick drags in multiple blocks of five different burn ages (areas burned 1, 2, 3, 4, or 5 years previously). We also assessed herbivore diversity using dung as a proxy. Tick presence was highest in areas burned 2-3 years previously. It was lowest in recently-burned areas (probably due to fire-induced mortality or loss of field-layer refugia) and areas burned ≥ 4 years previously (probably because the lack of palatable grass meant herbivore abundance was lower; this is supported by significantly lower herbivore presence in old burns and significant positive correlation between tick numbers and herbivore presence). Burn age and, to a lesser extent, block, were significantly related to tick presence and abundance at both larval and nymph stages. The model that best explained tick numbers, though, included the interaction between burn age and block due to substantial inter-block variability in mid-burn blocks relative to lower variability in blocks at the start or end of the burn cycle. This suggests that burn age and block-specific conditions together influence tick abundance, with habitat heterogeneity likely being an important modifier of the effect burning has on tick numbers. Although annual burning of large areas would not be feasible while maintaining suitable grazing, we suggest that additional annual burning of potential wildlife (and therefore tick) hotspots, such as around waterholes, could reduce tick populations and improve wildlife management

The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma

The melanoma-specific graded prognostic assessment (msGPA) assigns patients with brain metastases from malignant melanoma to 1 of 4 prognostic groups. It was largely derived using clinical data from patients treated in the era that preceded the development of newer therapies such as BRAF, MEK and immune checkpoint inhibitors. Therefore, its current relevance to patients diagnosed with brain metastases from malignant melanoma is unclear. This study is an external validation of the msGPA in two temporally distinct British populations.Performance of the msGPA was assessed in Cohort I (1997-2008, n=231) and Cohort II (2008-2013, n=162) using Kaplan-Meier methods and Harrell's c-index of concordance. Cox regression was used to explore additional factors that may have prognostic relevance.The msGPA does not perform well as a prognostic score outside of the derivation cohort, with suboptimal statistical calibration and discrimination, particularly in those patients with an intermediate prognosis. Extra-cerebral metastases, leptomeningeal disease, age and potential use of novel targeted agents after brain metastases are diagnosed, should be incorporated into future prognostic models.An improved prognostic score is required to underpin high-quality randomised controlled trials in an area with a wide disparity in clinical care

Relationship Between Time in Therapeutic Range and Comparative Treatment Effect of Rivaroxaban and Warfarin: Results From the ROCKET AF Trial

Background: Time in therapeutic range (TTR) is a standard quality measure of the use of warfarin. We assessed the relative effects of rivaroxaban versus warfarin at the level of trial center TTR (cTTR) since such analysis preserves randomized comparisons. Methods and Results: TTR was calculated using the Rosendaal method, without exclusion of international normalized ratio (INR) values performed during warfarin initiation. Measurements during warfarin interruptions >7 days were excluded. INRs were performed via standardized finger‐stick point‐of‐care devices at least every 4 weeks. The primary efficacy endpoint (stroke or non‐central nervous system embolism) was examined by quartiles of cTTR and by cTTR as a continuous function. Centers with the highest cTTRs by quartile had lower‐risk patients as reflected by lower CHADS2 scores (P<0.0001) and a lower prevalence of prior stroke or transient ischemic attack (P<0.0001). Sites with higher cTTR were predominantly from North America and Western Europe. The treatment effect of rivaroxaban versus warfarin on the primary endpoint was consistent across a wide range of cTTRs (P value for interaction=0.71). The hazard of major and non‐major clinically relevant bleeding increased with cTTR (P for interaction=0.001), however, the estimated reduction by rivaroxaban compared with warfarin in the hazard of intracranial hemorrhage was preserved across a wide range of threshold cTTR values. Conclusions: The treatment effect of rivaroxaban compared with warfarin for the prevention of stroke and systemic embolism is consistent regardless of cTTR

Evaluation of clinical prediction models (part 1):from development to external validation

Evaluating the performance of a clinical prediction model is crucial to establish its predictive accuracy in the populations and settings intended for use. In this article, the first in a three part series, Collins and colleagues describe the importance of a meaningful evaluation using internal, internal-external, and external validation, as well as exploring heterogeneity, fairness, and generalisability in model performance

Centerscope

Centerscope, formerly Scope, was published by the Boston University Medical Center "to communicate the concern of the Medical Center for the development and maintenance of improved health care in contemporary society.